Please login to the form below
pulmonary embolism
This page shows the latest pulmonary embolism news and features for those working in and with pharma, biotech and healthcare.
Zafgen shares tumble after FDA places hold on diabetes trial
This was abandoned in 2016 after two patients died in a phase 3 trial of the drug after suffering a pulmonary embolism.
Latest news
-
Boston Scientific makes $4.2bn play for UK’s BTG
Boston Scientific’s chief executive Michael Mahoney highlighted BTG’s cancer and pulmonary embolism portfolios – which include products to freeze and deliver radiotherapy or drugs to tumours and devices to dissolve
-
AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
as pulmonary embolism (PE) or deep vein thrombosis (DVT) and an uncompetitive dose.
-
FDA panel undermines Lilly and Incyte’s baricitinib hopes
baricitinib’s potential to cause side effects such as pulmonary embolism and venous thromboembolism.
-
AbbVie’s JAK inhibitor upadacitinib clears another phase III trial
There was a fatality from a stroke in the trial in a patient, plus one case of a pulmonary embolism, although AbbVie said these occurred in at-risk patients.
-
Xarelto beats aspirin for recurrent blood clots
Janssen's parent company Johnson &Johnson (J&J) said in a statement that up to 10% of people who have suffered a VTE (usually a deep vein thrombosis or pulmonary embolism)
More from news
Approximately 2 fully matching, plus 46 partially matching documents found.
Latest Intelligence
-
Modern anticoagulants threaten status quo
embolism in patients with AF and for the prevention of VTE in patients undergoing knee or hip replacement surgery. ... In one phase III trial, idrabiotaparinux sodium was non-inferior to warfarin in preventing the recurrent VTE at three months in
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary and benefits
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
-
Director – Healthcare PR
-
Salary TBC
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
